Earnings Call · Q3 FY2022·2022-11-07

Q3 22EPS -2.56%·Rev n/aQ2 22EPS +11.43%·Rev n/aQ1 22EPS +30.56%·Rev n/aQ4 21EPS +16.67%·Rev n/a⚠ consensus missing

Amphastar Pharmaceuticals, Inc. AMPH

Dan Dischner — CEO

Bill Peters — CFO and Executive Vice President of Finance

−9.4%1d on move date−9.9% vs SPY3d−5.4%5d−5.8%

Research tier

Behavioral profile computed for 2 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more AMPH calls or request research access.

More AMPH calls Browse calls Request research access